Shanghai Shen Lian Biomedical Corp (688098) — Capital Reinvestment Ratio

Latest as of September 2025: 0.59x

Shanghai Shen Lian Biomedical Corp (688098) has a Capital Reinvestment Ratio of 0.59x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.52 Million) in capital expenditures (CN¥12.62 Million). Check Shanghai Shen Lian Biomedical Corp tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.59x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥21.52 Million
CNY

Capital Expenditures

CN¥12.62 Million
CNY

Data as of

Sep 2025
Most recent filing

Shanghai Shen Lian Biomedical Corp Capital Reinvestment Ratio (2013–2025)

This chart tracks Shanghai Shen Lian Biomedical Corp's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 688098 cash generation efficiency.

Annual Capital Reinvestment Ratio for Shanghai Shen Lian Biomedical Corp (2013–2025)

Year-by-year Capital Reinvestment Ratio for Shanghai Shen Lian Biomedical Corp from 2013 to 2025. See 688098 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.37x CN¥33.08 Million CN¥45.23 Million ▲ +43.9%
2024 0.95x CN¥89.36 Million CN¥84.91 Million ▼ -97.4%
2023 36.77x CN¥3.53 Million CN¥129.63 Million ▲ +258.8%
2022 10.25x CN¥9.09 Million CN¥93.12 Million ▲ +390.8%
2021 2.09x CN¥90.12 Million CN¥188.16 Million ▲ +42.6%
2020 1.46x CN¥111.73 Million CN¥163.56 Million ▼ -24.3%
2019 1.93x CN¥53.81 Million CN¥104.09 Million ▲ +197.3%
2018 0.65x CN¥121.13 Million CN¥78.80 Million ▼ -53.1%
2017 1.39x CN¥74.61 Million CN¥103.44 Million ▼ -42.5%
2016 2.41x CN¥48.00 Million CN¥115.70 Million ▲ +77.4%
2015 1.36x CN¥30.86 Million CN¥41.93 Million ▲ +356.1%
2014 0.30x CN¥105.98 Million CN¥31.57 Million ▼ -56.2%
2013 0.68x CN¥51.79 Million CN¥35.23 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow